CD320 expression was also significantly correlated with age, sex, cancer stage, tumor grade, nodal metastasis status, and TP53 expression in patients who suffer from LIHC, and patients with high CD320 expression in LIHC exhibited a dismal survival rate in our study. The gene discussed is CD320; the disease is cancer.